These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 28880948)
1. Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice. Gallay PA; Chatterji U; Kirchhoff A; Gandarilla A; Gunawardana M; Pyles RB; Marzinke MA; Moss JA; Baum MM PLoS One; 2017; 12(9):e0184303. PubMed ID: 28880948 [TBL] [Abstract][Full Text] [Related]
2. Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc. Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Gunawardana M; Dawson LN; Olive TJ; Pyles RB; Baum MM PLoS One; 2018; 13(8):e0201952. PubMed ID: 30133534 [TBL] [Abstract][Full Text] [Related]
3. One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates. Denton PW; Othieno F; Martinez-Torres F; Zou W; Krisko JF; Fleming E; Zein S; Powell DA; Wahl A; Kwak YT; Welch BD; Kay MS; Payne DA; Gallay P; Appella E; Estes JD; Lu M; Garcia JV J Virol; 2011 Aug; 85(15):7582-93. PubMed ID: 21593172 [TBL] [Abstract][Full Text] [Related]
4. Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission. Mandal S; Kang G; Prathipati PK; Zhou Y; Fan W; Li Q; Destache CJ J Control Release; 2019 Jan; 294():216-225. PubMed ID: 30576746 [TBL] [Abstract][Full Text] [Related]
5. Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial. Vincent KL; Moss JA; Marzinke MA; Hendrix CW; Anton PA; Pyles RB; Guthrie KM; Dawson L; Olive TJ; Butkyavichene I; Churchman SA; Cortez JM; Fanter R; Gunawardana M; Miller CS; Yang F; Rosen RK; Vargas SE; Baum MM PLoS Med; 2018 Sep; 15(9):e1002655. PubMed ID: 30265679 [TBL] [Abstract][Full Text] [Related]
6. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941 [TBL] [Abstract][Full Text] [Related]
7. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. Denton PW; Krisko JF; Powell DA; Mathias M; Kwak YT; Martinez-Torres F; Zou W; Payne DA; Estes JD; Garcia JV PLoS One; 2010 Jan; 5(1):e8829. PubMed ID: 20098623 [TBL] [Abstract][Full Text] [Related]
8. Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice. Gallay PA; Ramirez CM; Baum MM Sci Rep; 2023 Mar; 13(1):4594. PubMed ID: 36944714 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Vaginally Administered Gel Containing Emtricitabine and Tenofovir Against Repeated Rectal Simian Human Immunodeficiency Virus Exposures in Macaques. Dobard CW; Makarova N; West-Deadwyler R; Taylor A; Dinh C; Martin A; Lipscomb J; Mitchell J; Khalil G; Garcia-Lerma G; Heneine W J Infect Dis; 2018 Sep; 218(8):1284-1290. PubMed ID: 29788316 [TBL] [Abstract][Full Text] [Related]
11. Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model. Destache CJ; Mandal S; Yuan Z; Kang G; Date AA; Lu W; Shibata A; Pham R; Bruck P; Rezich M; Zhou Y; Vivekanandan R; Fletcher CV; Li Q Antimicrob Agents Chemother; 2016 Jun; 60(6):3633-9. PubMed ID: 27044548 [TBL] [Abstract][Full Text] [Related]
12. Electrospun fibers for vaginal administration of tenofovir disoproxil fumarate and emtricitabine in the context of topical pre-exposure prophylaxis. Nunes R; Bogas S; Faria MJ; Gonçalves H; Lúcio M; Viseu T; Sarmento B; das Neves J J Control Release; 2021 Jun; 334():453-462. PubMed ID: 33961916 [TBL] [Abstract][Full Text] [Related]
13. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Patterson KB; Prince HA; Kraft E; Jenkins AJ; Shaheen NJ; Rooney JF; Cohen MS; Kashuba AD Sci Transl Med; 2011 Dec; 3(112):112re4. PubMed ID: 22158861 [TBL] [Abstract][Full Text] [Related]
14. Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. Radzio J; Aung W; Holder A; Martin A; Sweeney E; Mitchell J; Bachman S; Pau CP; Heneine W; García-Lerma JG PLoS One; 2012; 7(12):e50632. PubMed ID: 23226529 [TBL] [Abstract][Full Text] [Related]
15. Highly synergistic drug combination prevents vaginal HIV infection in humanized mice. Baum MM; Ramirez CM; Moss JA; Gunawardana M; Bobardt M; Gallay PA Sci Rep; 2020 Aug; 10(1):12995. PubMed ID: 32747682 [TBL] [Abstract][Full Text] [Related]
16. An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil Fumarate. McGowan IM; Kunjara Na Ayudhya RP; Brand RM; Marzinke MA; Hendrix CW; Johnson S; Piper J; Holtz TH; Curlin ME; Chitwarakorn A; Raengsakulrach B; Doncel G; Schwartz JL; Rooney JF; Cranston RD AIDS Res Hum Retroviruses; 2022 Apr; 38(4):279-287. PubMed ID: 34541872 [TBL] [Abstract][Full Text] [Related]
17. Changes in kidney function among men having sex with men starting on demand tenofovir disoproxil fumarate - emtricitabine for HIV pre-exposure prophylaxis. Liegeon G; Antoni G; Pialoux G; Capitant C; Cotte L; Charreau I; Tremblay C; Cua E; Senneville E; Raffi F; Meyer L; Molina JM; J Int AIDS Soc; 2020 Feb; 23(2):e25420. PubMed ID: 32086878 [TBL] [Abstract][Full Text] [Related]
18. A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges. Kovarova M; Swanson MD; Sanchez RI; Baker CE; Steve J; Spagnuolo RA; Howell BJ; Hazuda DJ; Garcia JV J Antimicrob Chemother; 2016 Jun; 71(6):1586-96. PubMed ID: 27002074 [TBL] [Abstract][Full Text] [Related]
19. Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? Taramasso L; Riccardi N; Del Puente F; Bruzzone B; Ripamonti D; D'Ambrosio B; Viscoli C; Di Biagio A AIDS Res Hum Retroviruses; 2018 Feb; 34(2):168-170. PubMed ID: 29166777 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques. Massud I; Cong ME; Ruone S; Holder A; Dinh C; Nishiura K; Khalil G; Pan Y; Lipscomb J; Johnson R; Deyounks F; Rooney JF; Babusis D; Park Y; McCallister S; Callebaut C; Heneine W; García-Lerma JG J Infect Dis; 2019 Oct; 220(11):1826-1833. PubMed ID: 31362305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]